100%

Scanned image of the page. Keyboard directions: use + to zoom in, - to zoom out, arrow keys to pan inside the viewer.

Page Options

Download this Issue

Share

Something wrong?

Something wrong with this page? Report problem.

Rights / Permissions

This collection, digitized in collaboration with the Michigan Daily and the Board for Student Publications, contains materials that are protected by copyright law. Access to these materials is provided for non-profit educational and research purposes. If you use an item from this collection, it is your responsibility to consider the work's copyright status and obtain any required permission.

November 14, 2002 - Image 10

Resource type:
Text
Publication:
The Michigan Daily, 2002-11-14

Disclaimer: Computer generated plain text may have errors. Read more about this.


10

10A - The Michigan Daily - Thursday, November 14, 2002

Blue wary of
matchup with
winless 'Cats
MEN'S SOCCER
1EN
CONFERENCE
STATE COLLEGE

By Gennaro Filice
Daily Sports Writer

AP PHOTO/Daily
The Mississippi State offensive line might not be the only group putting the hurt on
Alabama after the NCAA reopens its investigation into the Crimson Tide.
NCAA wants another
look at Crimson Tide

BIRMINGHAM, Ala. (AP) - A
recruiting scandal that landed Alaba-
ma's football program on probation
could go before the NCAA again
based on new information made public
in court last week.
Tom Yeager, chairman of the
infractions committee, said yesterday
the NCAA is evaluating claims
revealed during a hearing in which a
former high school coach pleaded
guilty to accepting $150,000 to steer
a prized recruit to Alabama. The plea
directly implicated two former
Alabama coaches.
The enforcement staff could either
shelve the matter or send it to the com-
mittee for further review, Yeager said in
a telephone interview with The Associ-
ated Press. No decision has been made.
Yeager declined comment on
whether additional penalties were pos-
sible against Alabama, which in Febru-
ary was hit with scholarship
limitations, a two-year bowl ban and
five years of probation.
Yeager said the staff would pass
along only information that was sub-
stantially different from what the com-
mittee previously heard. But it's not
uncommon for the committee to
receive reports about infractions it pre-
viously considered, he said.
"In some cases it's a lingering chain
of events that can occur," Yeager said.
University counsel Stan Murphy
referred a call to university spokesman
Larry White, who declined comment.
An NCAA investigator was in court
last week in Memphis, Tenn., as for-
mer Trezevant High School coach

Lynn Lang pleaded guilty to a federal
racketeering charge and agreed to
cooperate with investigators. A former
Lang assistant, Milton Kirk, previously
pleaded guilty.
With his plea, Lang agreed to the
government's contention that he took
money from Logan Young, a wealthy
Memphis businessman and longtime
Alabama booster, to steer defensive
lineman Albert Means toward Alaba-
ma. Young is a longtime friend of
Alabama athletic director Mal Moore.
Lang said he was referred to Young
by Ivy Williams, a former Alabama
assistant, and that he discussed the deal
with Ronnie Cottrell, a former Alaba-
ma recruiting coordinator.
Assistant U.S. Attorney Fred God-
win also said in court that Williams
suggested that Lang arrange for some-
one to take the place of Means during
a college entrance test.
The disclosures appeared to be at
odds with the NCAA's previous deci-
sion in the Alabama case since the
sanctioning body did not directly
implicate the Alabama coaching staff
in any major recruiting violations.
Alabama was not cited for lack of
institutional control, a violation that
could have brought more severe sanc-
tions, possibly even the "death penal-
ty," which shuts down a program for at
least one season.
The NCAA cleared Williams of
lying to an NCAA investigator about
the scandal after initially accusing him
of providing false information about
the case. Williams has repeatedly
denied any wrongdoing.

The Northwestern men's soccer team finished the
season in the Big Ten cel-
lar with a 0-6 mark in j .
conference play. In these SfTA:iTE COLLEGE
six games, the Wildcats
were outscored by a co m- Wh:Mcigan (3-3 Big
bined mark of 12-1. On Ten, 9.6.2 overall) vs.
Oct.27,Nortwesern Northwestern (-6, 8&11)
When: 4 p.m. today
suffered its worst loss of Latest: The Wolverines
the season in a 5-0 shel- open the Big Ten Tourna-
lacking by Michigan. So, ment as the No.2 seed,but
what does Michigan are expecting a battle from
coach Steve Burns think winless Northwestern.
of this Wildcats squad,
which the Wolverines face off against today in the
first round of the Big Ten Tournament?
"They're like a caged animal," said Burns.
"They're very dangerous."
Today, the second-seeded Wolverines go to battle
against the seventh-seeded Wildcats, and although
Northwestern served as the Big Ten's punching bag
in the regular season, Burns refuses to look ahead to
a potential second-round matchup against either
Ohio State or Michigan State.
"We don't know what they're going to put togeth-
er," Burns said. "I think that they could put together
a great game and play with a ferocity which we just
haven't seen from them, and they could catch us off
guard. So a lot of the training we are doing right now
is psychological, in the sense that we don't want our
players looking past this game because this is the
Three's of a kind
In just the program's third year, Steve Burns' team
is in position to win its first conference crowd.
Michigan was just 3-3 in Big Ten play. But thanks
to a very balanced conference, and several teams
also with 3-3 records, the Wolverines are the No.
2 seed in this year's Big Ten Tournament because
of goal differential.
BIG TEN PTs. GF GA
1. Indiana 6-0-0 18 19 5
2. Michigan 3-3-0 9 11 7
3. Ohio State 3-3-0 9 8 7
4. Penn State 3-3-0 9 5 5
5. Wisconsin 3-3-0 9 8 11
6. Michigan State 3-3-0 9 7 12
7. Northwestern 0-6-0 0 1 12

JASON COOPER/Daily
Knox Cameron and the rest of the Michigan soccer team are hoping that Northwestern doesn't grab its first
conference win of the year at the Wolverines' expense in the Big Ten Tournament's first round today.

biggest game right here for us."
The Wolverines will attempt to repeat their second
best offensive output of the year (the aforementioned
5-0 drubbing), a final score that Burns says may
have been a bit deceiving.
"We had a very good game against Northwest-
ern," Burns said. "Four of the five goals we scored in
that game were 'nice' goals. But, 'nice' goals don't
come all the time. So, I think you could say that we
were in form and we finished well that day, but it
certainly could have been a much tighter score."
Although the game may have been closer than the
score indicated, Burns expects the Wildcats to incor-
porate a different game plan than the "toe-to-toe"
attack that they utilized Oct. 27.
"If I were their coach, I would look to pack it in'
Burns said. "I would look to keep it a low scoring
affair, and I think we'll see that."
The Wildcats are paced by freshman scoring
machine Tito Lara. The forward led Northwestern
with 13 points on six goals and one assist. In goal,
Northwestern boasts a solid keeper in J.D. Martin,
who has produced a 1.29 goals-against average.
Although these two Wildcats could present Michi-
gan with a challenge, the player who may hinder the
Wolverines' production the most may not even be on

the Northwestern roster.
Michigan will have to play through the Big Ten
tournament without its second-leading point scorer,
Knox Cameron, who is currently representing the
United States on the Under-20 national team.
"What we've learned so far (during Cameron's
absence) is that you can think about how you're
going to play without one of your better players on
the field, but until you actually get some games, that
may not be true, Burns said.
But Burns does believe he has made leeway in
replacing Cameron.
"The two scenarios that we thought we'd use with-
out Knox Cameron have both proved to be false,"
Burns said. "We're now on our third, and we think
we've figured it out in terms of Ian Hirschfield and
Karl Lopata at attacking-mid positions."
If Michigan's adjustments are successful, and it
beats Northwestern, it will face one of two archrivals
tomorrow: Both teams, Ohio State and Michigan
State, finished tied with the Wolverines for second
place in the Big Ten regular season. The prospective
matchup against either team excites Burns.
"Both of these teams would give us a great game,
and we would look forward to that if we can get past
Northwestern," Burns said.

I

I

or

It's in with the old for
Giants: Alou takes over

I

SAN FRANCISCO (AP) - To
handle their veteran team, the San
Francisco Giants turned to an old
pro: Felipe Alou.
The 67-year-
old Alou becameo
the oldest manag-
er to take over a
club since Casey
Stengel four
decades ago. Not
that Alou was
worrying about
his age after the
National LeagueA
champions hired
him yesterday to replace Dusty
Baker.
"I'm a soldier of this game," said
Alou, who played for San Francisco

IL

Ciotr e tve iInection
medroxyprogesterone acetate injectable suspension

3'irtk control you tkiryc agoutt jus-t iI- x a year

it v +

DEPO-PROVERAI Contraceptive Injection
(medroxyprogesterone acetate injectable suspension. USP)
This product is intended to prevent pregnancy. It does not protect against HIV
infection (AIDS) and other sexually transmitted diseases.
What is DEPO-PROVERA Contraceptive Injection?
DEPO-PROVERA Contraceptive Injection is a form of birth control that is liven as an
intramuscular injection (a shot) in the buttock or upper arm once every 3 months (I3 weeks). To
continue your contraceptive protection, you must return for your next injection promptly at the
end of 3 months (13 weeks). DEPO-PROVERA contains medroxyprogesterone acetate, a
chemical similar to (but not the same as) the natural hormone progesterone, which is produced
by your ovaries during the second half of your menstrual cycle. DEPO-PROVERA acts by
preventing your egg cells from ripening. If an egg is not released from the ovaries during your
menstrual cycle, it cannot become fertilized by sperm and result in pregnancy. DEPO-PROVERA
also causes changes in the lining of your uterus that make it less likely or pregnancy to occur
How effective is DEPO-PROVERA Contraceptive Injection?
The efficacy of DEPO-PROVERPA Contraceptive Injection depends on following the
recommended dosage schedule exactly (see "How often du I get my shotsof DEPO-PROVEA
Contraceptive Injection?"). To make sure you are not pregnant when you first get
DEPO-PROVERA Contraceptive Injection, your first injection must be given ONLY during
the first 5 days of a normal menstrual period; ONLY within the first S days after childbirth if not
breast-feeding; and, if exclusively breast-feeding, ONLY at the sixth week after childbirth, It is a
long-term injectable contraceptive when administered at 3-month (13-week) intervals.
DEPO-PROVERA Contraceptive Injection is over 99% effective, making it one of the most reliable
methods of birth control available. This means that the average annual pregnancy rate is less than
one for every 100 women who use DEPO-PROVERA. The effectiveness of most contraceptive
methods depends in part on how reliably each woman uses the method. The effectiveness of
DEPO-PROVERA depends only on the patient returning every 3 months (13 weeks) for her next
injection. Your health-care provider will help you compare DEPO-PROVERA with other
contraceptive methods and give you the information you need in order to decide which
contraceptive method is the right choice for you.
The following table shows the percent of women who got pregnant while using different kinds of
contraceptive methods, It gives both the lowest expected rate of pregnanty the rate expected
in women who use each method exactly as it should be used)and the typical rate of pregnancy
(which includes women who became pregnant because they forgot to use their birth control or
because they did not follow the directions exactly).
Percent of Women Experiencing an Accidental Pregnancy
in the First Year of Continuous Use

" if you have had cancer of the breast
" if you have had a stroke
" if you have or have had blood clots (phlebitis) in your legs
- if you have problems with your liver or liver disease
- if you are allergic to DEPO-PROVERA (medroxyprogesterone acetate or any of its other
ingredients).
What other things should I consider before using DEPO-PROVERA
Contraceptive Injection?
You will have a physical examination before your doctor prescnbes DEPO-PROVERA. It is
important to tell your health-care provider if you have any of the following:
* a family history of breast cancer
" an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lumps, or
bleeding from your nipples
" kidney disease
- irregular or scanty menstrual periods
" high blood pressure
" migraine headaches
"asthma
Sepilepsy (convulsions or seizures)
"diabetes or a family history of diabetes
" a history of depression
" if you are taking any prescnption or over-the-counter medications
This product is intended to prevent pregnancy. It does not protect against
transmission of HIV (AIDS) and other sexually transmitted diseases such as
chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis.
What if I want to become pregnant after using DEPO-PROVERA Contraceptive
Injection?
Because DEPO-PROVERA is a long-acting birth control method, it takes some time after your last
injection for its effect to wear off Based on the results from a large study done in the United States,
for women who stop using DEPO-PROVERA in order to become pregnant, it is expected that
about half of those who become pregnant will do so in about 10 months after their last injection:
about two thirds of those who become pregnant will do so in about 12 months: about 83% of
those who become pregnant will do so in about 15 months; and about 93% of those who become
regnant will do so in about I 8 months after their last injection. The length of time you use
O-PROVERA has no effect on how ong it takes you to become pregnant after you stop using it
What are the risks of using DEPO-PROYERA Contraceptive Injection?
I .rregular Menstrual Bleeding
The side effect reported most frequently by women who use DEPO-PROVERA for
contraception is a change in their normal menstrual cycle. During the first year of using
DEPO-PROVERA. you might have one or more of the following changes: irregular or
unpredictable bleeding or spotting, an increase or decrease in menstrual bleeding, or no bleeding
at all. Unusually heavy or continuous bleeding, however is not a usual effect of DEPO-PROVERA;
and if this happens, you should see your health-care provider right away. With continued use of
DEPO-PROVERA, bleeding usually decreases, and many women stop having periods completely.
In clinical studies of DEPO-PROVERA, 55% of the women studied reported no menstrual
bleeding (amenorrhea) after I year of use, and 68% of the women studied reported no menstrual
bleeding after 2 years of use. The reason that your periods stop is because DEPO-PROVERA
causes a resting state in your ovaries. When your ovaries do not release an egg monthly, the

6.Otlter Risks
Women who use hormone-based contraceptives may have an increased risk of blood clots or
stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg will begin
to develop outside of the uterus (ectopic pregnancy). While these events are rare, you should
tell your health-care provider if you have any of the problems listed in the next section.
What symptoms may signal problems while using DEPO-PROVERA
Contraceptive Injection?
Call your health-care provider immediately if any of these problems occur following an injection
of DEPO-PROVERA:
sharp chest pain, coughing up of blood, or sudden shortness of breath (indicating a possible clot
in the lung)
e sudden severe headache or vomiting, dizziness or fainting, problems with your eyesight or
speech, weakness, or numbness in an arm or leg (indicating a possible stroke)
- severe pain or swelling in the calf (indicating a possible clot in the leg)
" unusually heavy vaginal bleeding
* severe pain or tenderness in the lower abdominal area
p ersistent pain, pus, or bleeding at the injection site
What are the possible side effects of DEPO-PROVERA contraceptive Injection?
I.Weight Goin
You may experience a weight gain while you are using DEPO-PROVERA. About two thirds of
the women who used DEPO-PROVERA in clinical trials reported a weight gain of about 5 pounds
during the first year of use. You may continue to gain weight after the first year Women in one
large study who used DEPO-PROVERA for 2 years gained an average total of 8.1 pounds over
those 2 years, or approximately 4 pounds per year Women who continued for 4 years gained an
average total of 3.8 pounds over those 4 years, or approximately 3.5 pounds per year Women
who continued for 6 years gained an average total of I 6.5 pounds over those 6 years, or
approximately 2.75 pounds per year
2.Qdner Side Effects
In a clinical study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some
women reported the following effects that may or may not have been related to their use of
DEPO-PROVERA: Irregular menstrual bleeding, amenorrhea, headache, nervousness, abdominal
cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps, nausea, vaginal
discharge or irrtation, breast swelling and tenderness, bloating, swelling of the hands or feet,
backache, depression, insomnia, acne, pelvic pain, no hair growth or excessive hair loss, rash, hot
flashes, and joint pain. Other problems were reported by very few of the women in the clinical
tnials, but some of these could be serious. These include convulsions, jaundice, urinary tract
infections, allergic reactions, fainting, paralysis, osteoporosis, lack of return to fertility deep vein
thrombosis, pulmonary embolus. breast cancer; or cervical cancer. If these or any other problems
occur during your use of DEPO-PROVERA, discuss them with your health-care provider.
Should any recautions be followed during use of DEPO-PROVERA
Contraceptive Injection?
I.Missed Periods
Dunng the time you are using DEPO-PROVERA for contraception, you may skip a period, or your
penods may stop completely If you have been receiving your DEPO-PROVEPA injections
regularly every 3 months (13 weeks), then you are probably not pregnant However; if you think
that you may be pregnant, see your health-care provider
2.Loborotory Test Interactions
If you are scheduled for any laboratory tests, tell your health-care provider that you are using
DEPO-PROVEPA for contraception. Certain blood tests are affected by hormones such as

in the 1950s and '60s. "The matter
of energy and enthusiasm, some-
body else is going to have to evalu-
ate that."
Stengel was 71 when the New
York Mets lured him out of retire-
ment in October 1961 to manage
them the next year in their first sea-
son, according to the Elias Sports
Bureau and the Hall of Fame.
It's been a good week for older
coaches. On Tuesday, the NBA's
Memphis Grizzlies hired Hubie
Brown, 69.
Alou, the former Montreal man-
ager and a bench coach for Detroit
last season, was excited to return to
the Giants. He inherits a team led
by five-time MVP Barry Bonds.
"I'm going back home to where I
started and, hopefully, I'm going to
end it right there," he said.
Alou agreed to a three-year con-
tract and becomes the oldest man-
ager in the major leagues. He was
691-717 in 10 seasons managing
the Expos.
The popular Baker did not have
his contract renewed by the Giants
after coming within six outs of the
World Series championship. Baker is
talking with the Chicago Cubs about
becoming their manager. Alou's son
Moises plays for the Cubs.
"I was happily surprised," Moi-
ses said. "For him to get a job with
a team like the Giants is awesome."
Alou played for the Giants from
1958-63 as part of a solid 17-sea-
son major league career in which
he hit .286 with 206 homers and
852 RBIs.
He also spent 1970 and part of
1971 in the Bay area playing for
the Oakland Athletics.
On the Giants, he joined brothers
Matty and Jesus in an all-Alou out-
field in some games.
That's one of the highlights of
his playing days in San Francisco,
along with a string of nine consec-
utive hits.
"When I received the first notice
that I might be the guy, or the club

Lowest
Method Expected Typical
DEPO-PROVERA 03 0.3
Implants (Norplant) 0.2 0.2°
Female sterilization 0.2 0.4
Male Sterilization 01 0.15

Back to Top

© 2017 Regents of the University of Michigan